We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
- Authors
Sterchi, J. Michael; Wells, H. Bradley; Case, L. Douglas; Spurr, Charles L.; White, Douglas R.; Richards, Frederick; Muss, Hyman B.; Jackson, Don V.; Stuart, John J.; Cooper, M. Robert; Sterchi, J M; Wells, H B; Case, L D; Spurr, C L; White, D R; Richards, F; Muss, H B; Jackson, D V; Stuart, J J; Cooper, M R
- Abstract
Seventy patients with Stage I and II malignant melanoma were randomized to treatment with either intravenous dacarbazine alone or intravenous dacarbazine plus intradermal injection of the methanol-extracted residue of bacillus Calmette-Guerin (BCG). Analysis of treatment failed to reveal a statistically significant difference between these two forms of treatment in Stage I and II patients. It is possible that chemoimmunotherapy may increase survival in Stage II patients, but this possibility should be interpreted with caution.
- Publication
Cancer (0008543X), 1985, Vol 55, Issue 4, p707
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/1097-0142(19850215)55:4<707::AID-CNCR2820550406>3.0.CO;2-5